Clin2
NCT07039760Possibly a fitNot yet recruiting

Asciminib with or without sildenafil for recurrent brain tumors

Brain Tumor

Treatments studied

Part of Brain & nervous system, Cancer clinical trials.

This study tests whether adding a drug called sildenafil (commonly known as Viagra) to the cancer drug asciminib can help treat brain tumors that have come back or grown after previous treatment. The goal is to see if the combination is safe and may slow tumor growth.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
12 people
Ages
18 years to 39 years
Study type
Interventional

Who can take part

  • You are between 18 and 39 years old.
  • You have a brain tumor that has come back or grown, and it is in the main part of the brain.
  • You are healthy enough to have surgery or a biopsy to remove or sample the tumor.
  • Your blood counts (white cells, platelets, and hemoglobin) are within acceptable levels.
  • Your kidney and liver function are normal or close to normal.
  • You can swallow pills and are willing to have follow-up visits.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06807619Recruiting· Phase 1
Sotorasib for people with brain tumors needing surgery

This study tests a drug called sotorasib in people with brain tumors who are already scheduled for surgery or a biopsy. It may help find out if the drug can reach and treat the tumor.

Basking Ridge, New Jersey
NCT02800486Recruiting· Phase 2
Targeted antibody plus repeat radiation for recurrent brain tumors

This trial studies giving cetuximab (a targeted antibody) directly into an artery along with repeat radiation to treat certain recurring or treatment-resistant brain tumors. It may help by delivering the drug more directly to tumor areas and testing whether this approach can control the disease after it comes back.

New York, New York
NCT07136428Recruiting· Phase 1/Phase 2
Asciminib for HER2+ breast cancer that has spread to the brain

This trial tests the drug asciminib for people with HER2-positive breast cancer that has spread to the brain and is growing. It may be an option if you have already tried standard treatments like T-DXd and tucatinib.

Durham, North Carolina
NCT06883747Recruiting· Early Phase 1
Study of BMS-986504 for recurrent brain tumor

This trial tests an experimental drug, BMS-986504, for people with recurrent glioblastoma (a type of brain cancer). The drug targets a specific genetic change in the tumor. It aims to see if the drug can help shrink or slow the tumor.

Phoenix, Arizona
NCT05689619Recruiting
Silibinin after one brain metastasis surgery for lung or breast cancer

This trial studies silibinin, a natural substance, to help prevent brain metastasis from coming back after surgery. It is for people with lung (NSCLC) or breast cancer who have exactly one small brain metastasis that is fully removed and has a specific lab marker in the brain tissue.

Genova
NCT06800092Not yet recruiting· Phase 2/Phase 3
Sildenafil to prevent memory problems from breast cancer treatment

This study tests if sildenafil (a blood pressure medicine) can help prevent memory and thinking problems that some women with breast cancer may experience. It might help protect your brain during treatment.

Galveston, Texas

Hear when a new Brain Tumor trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.